Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

87.11
-0.3600-0.41%
Post-market: 87.02-0.0900-0.10%19:30 EDT
Volume:1.09M
Turnover:94.72M
Market Cap:12.27B
PE:-38.14
High:88.46
Open:87.90
Low:85.94
Close:87.47
52wk High:95.49
52wk Low:20.45
Shares:140.86M
Float Shares:122.00M
Volume Ratio:1.09
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:26.36
PE(LYR):-7,144.26

Loading ...

Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 26, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]